27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Neos Therapeutics Inc (NASDAQ: NEOS) and Aytu BioScience Inc (NASDAQ: AYTU) shares are rising today in the premarket session, though there is no news on both companies.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
- The investors are reacting to the companies' respective special meetings of stockholders related to the proposed merger between Aytu and Neos that will happen today.
- Each company's stockholders on record as of February 5 will be eligible to receive notice of vote at their respective company's special meeting.
- Last week, an independent proxy advisory firm Glass, Lewis & Co, recommended Neos Therapeutics stockholders vote "FOR" the merger. Another independent proxy advisory firm, Institutional Shareholder Services Inc., also recommended Neos Therapeutics stockholders vote "FOR" the deal.
- Neos stockholders will receive 0.1088 Aytu shares upon merger closing, valuing the all-stock transaction at approximately $44.9 million.
- The combined company will operate under Aytu Biopharma Inc moniker.
- Price Action: NEOS and AYTU shares are trading 63.8% and 23.1% higher at $1.9 and $11.89, respectively, in premarket trading on the last check Thursday.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.